Srikant C B, Murthy K K, Escher E E, Patel Y C
Fraser Laboratories, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Endocrinology. 1992 May;130(5):2937-46. doi: 10.1210/endo.130.5.1349280.
Pharmacological studies have suggested that the somatostatin (SS) receptor is heterogeneous and may exhibit subtypes selective for SS-14 and SS-28. Whether this heterogeneity can be explained by separate molecular forms of the receptor protein is unclear. In the present study, we have developed a novel photosensitive azido derivative of the octapeptide SS analog Tyr3 SMS (EE 581) and used it as a photoaffinity probe to characterize the molecular components of the SS receptor in five receptor positive tissues (normal rat brain, pituitary, pancreas, and adrenal cortex, and mouse AtT-20 pituitary tumor cells). [125I]EE-581 labeled specific high affinity binding sites in all these tissues (Kd range 1.3-1.67 nM). Photoaffinity labeled membrane SS receptors were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by autoradiography. Three specifically labeled SS receptor proteins of 80 kilodaltons (kDa), 58 kDa, and 32 kDa were identified and exhibited a tissue-specific distribution. The 58 kDa species was the exclusive form in pancreas, adrenal cortex, and AtT-20 cells and the dominant form in brain. The 32 kDa receptor protein was expressed as a minor form (ratio of 58 kDa:32 kDa 3:1), exclusively in brain. The 80 kDa receptor was found only in the pituitary where it occurred as the sole SS receptor species. Competition experiments showed that the 58 kDa and 32 kDa receptor proteins in brain reacted with SS-14 greater than SS-28; in contrast, the 58 kDa protein in AtT-20 cells bound SS-28 greater than SS-14 suggesting the existence of distinct subtypes of the 58 kDa receptor in these two tissues. These data represent the first systematic evaluation of the molecular forms of SS receptor proteins by photoaffinity labeling in different target tissues and provide direct evidence for molecular heterogeneity and SS-14/SS-28 selectivity; a major 58 kDa protein present in most tissues, an additional 32 kDa protein uniquely expressed in brain, and an 80 kDa protein exclusive to the normal pituitary.
药理学研究表明,生长抑素(SS)受体具有异质性,可能表现出对SS - 14和SS - 28有选择性的亚型。尚不清楚这种异质性是否可以用受体蛋白的不同分子形式来解释。在本研究中,我们开发了一种新型的八肽SS类似物Tyr3 SMS(EE 581)的光敏叠氮衍生物,并将其用作光亲和探针来表征五种受体阳性组织(正常大鼠脑、垂体、胰腺、肾上腺皮质和小鼠AtT - 20垂体肿瘤细胞)中SS受体的分子成分。[125I]EE - 581在所有这些组织中标记了特异性高亲和力结合位点(Kd范围为1.3 - 1.67 nM)。通过十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳随后进行放射自显影分析光亲和标记的膜SS受体。鉴定出三种特异性标记的80千道尔顿(kDa)、58 kDa和32 kDa的SS受体蛋白,并呈现出组织特异性分布。58 kDa的蛋白是胰腺、肾上腺皮质和AtT - 20细胞中的唯一形式,也是脑中的主要形式。32 kDa的受体蛋白仅在脑中以次要形式表达(58 kDa与32 kDa的比例为3:1)。80 kDa的受体仅在垂体中发现,是垂体中唯一的SS受体种类。竞争实验表明,脑中58 kDa和32 kDa的受体蛋白与SS - 14的反应大于与SS - 28的反应;相反,AtT - 20细胞中的58 kDa蛋白与SS - 28的结合大于与SS - 14的结合,这表明在这两种组织中58 kDa受体存在不同的亚型。这些数据代表了通过光亲和标记对不同靶组织中SS受体蛋白分子形式的首次系统评估,并为分子异质性和SS - 14/SS - 28选择性提供了直接证据;大多数组织中存在一种主要的58 kDa蛋白,脑中独特表达一种额外的32 kDa蛋白,正常垂体中则存在一种80 kDa的专属蛋白。